Allergy

Now, A Cancer Drug That Helps Identify Dormant HIV

Researchers from the University of North Carolina at Chapel Hill in collaboration with scientists from the Harvard School of Public Health, National Cancer Institute, Merck and the University of California have identified a drug employed in treating certain types of lymphoma that help dislodge a hidden virus in patients receiving treatment for HIV.

Merck Second-Quarter Earnings Preview: A Glimpse

Based on analyst estimates, Merck & Co. will report earnings of $1.01 a share on sales of about $12.16 billion -- an increase of 0.1 percent from the year-earlier quarter. The company posts its second-quarter earnings on Friday, before the opening bell.

Scientists See AIDS Vaccine Within Reach After Decades

A 2009 clinical trial in Thailand was the first to show it was possible to prevent HIV infection in humans. Since then, discoveries have pointed to even more powerful vaccines using HIV-fighting antibodies. Now scientists believe a licensed vaccine is within reach.

HIV 'Superinfection' Boosts Immune Response

Women infected with two separate human immunodeficiency virus strains have a stronger immune response than women infected with a single HIV strain, a finding that could assist in producing the elusive anti-HIV vaccine, according to a new study published in the journal PLoS Pathogens.

Anthony Shadid, NYT's Foreign Correspondent, Dies in Syria

Renowned and respected, Anthony Shadid of the New York Times died on Thursday of an asthma attack in Syria. The entire journalism community mourns his death, remembering him for his accurate and moving stories on the Middle East and the peoples' suffering in the region.

Pages

EDITOR'S PICK